---
title: 'Motive and Opportunity: MYC rearrangements in high-grade B-cell lymphoma with
  MYC and BCL2 rearrangements-an LLMPP study'
date: '2024-05-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38701426/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240504180813&v=2.18.0.post9+e462414
source: Blood
description: 'Rearrangements that place the oncogenes MYC, BCL2, or BCL6 adjacent
  to superenhancers are common in mature B-cell lymphomas. Lymphomas with diffuse
  large B-cell lymphoma (DLBCL) or high-grade morphology with both MYC and BCL2 rearrangements
  are classified as high-grade B-cell lymphoma with MYC and BCL2 rearrangements ("double
  hit": HGBCL-DH-BCL2) and are associated with aggressive disease and poor outcomes.
  Although it is established that MYC rearrangements involving immunoglobulin (IG)
  loci ...'
disable_comments: true
---
Rearrangements that place the oncogenes MYC, BCL2, or BCL6 adjacent to superenhancers are common in mature B-cell lymphomas. Lymphomas with diffuse large B-cell lymphoma (DLBCL) or high-grade morphology with both MYC and BCL2 rearrangements are classified as high-grade B-cell lymphoma with MYC and BCL2 rearrangements ("double hit": HGBCL-DH-BCL2) and are associated with aggressive disease and poor outcomes. Although it is established that MYC rearrangements involving immunoglobulin (IG) loci ...